Poseida Therapeutics to Present anti-PSMA CAR-T Preclinical Data at the Society for Immunotherapy of Cancer (SITC … – GlobeNewswire (press release)
|
Poseida Therapeutics to Present anti-PSMA CAR–T Preclinical Data at the Society for Immunotherapy of Cancer (SITC …
GlobeNewswire (press release) SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene therapy technologies into lifesaving cell therapies, today announced that preclinical data on P-PSMA-101, … |
